NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026
Go back to NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) to Report Full Year 2025 Financial Results and Provide a Corporate Update on March 24, 2026| (NASDAQ: NRXP) | Delayed: 3.90 -0.07 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.97 | 52 Week High | $ | |||
| Open | $3.99 | 52 Week Low | $ | |||
| Day High | $4.17 | P/E | N/A | |||
| Day Low | $3.83 | EPS | $ | |||
| Volume | 713,081 | |||||

